Prodia Stem Cell

Prodia Stem Cell (ProSTEM) is a prominent Indonesian biotechnology company specializing in the processing, storage, and clinical research of stem cells. Established in 2010 as part of the Prodia Group ecosystem, it was the first laboratory in Indonesia to receive a license from the Ministry of Health for stem cell banking and processing. The company operates a state-of-the-art, GMP-certified facility known as the Advanced Therapy Cell Therapy-Production Laboratory (ACT-PLab), which focuses on umbilical cord blood, umbilical cord tissue, and mesenchymal stem cells. ProSTEM maintains a robust research pipeline with over 12 registered clinical trials targeting regenerative medicine across diverse indications such as cerebral palsy, osteoarthritis, and stroke. Through its high-quality cell therapy products and advanced cryopreservation services, ProSTEM aims to lead the development of innovative treatments for degenerative and life-threatening diseases in Asia.